A potential therapeutic drug for osteoporosis: prospect for osteogenic LncRNAs.
Meng F, Yu Y, Tian Y, Deng M, Zheng K, Guo X, Zeng B, Li J, Qian A, Yin C.
Meng F, et al. Among authors: li j.
Front Endocrinol (Lausanne). 2023 Aug 3;14:1219433. doi: 10.3389/fendo.2023.1219433. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 37600711
Free PMC article.
Review.